SCHEMBL4464960

SCHEMBL4464960

CC1CC(C#N)(Nc2ccc(I)cc2)CCN1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.37
CYP1A2 P05177 1/20 0.37
GAA P10253 1/20 0.35
CTSK P43235 3/20 0.34
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA4 P22748 2/20 0.34
CA5A P35218 2/20 0.34
CA7 P43166 2/20 0.34
CA9 Q16790 2/20 0.34
CA13 Q8N1Q1 2/20 0.34
CA14 Q9ULX7 2/20 0.34
CTSS P25774 2/20 0.34
CTSB P07858 1/20 0.34
OPRM1 P35372 1/20 0.33
FPR2 P25090 3/20 0.32
EPHX2 P34913 2/20 0.32
CTSL P07711 1/20 0.31
PREP P48147 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4465130 0.80 CYP1A2 (0.45) SMN1; SMN2CYP1A2GAACTSKCA12
SCHEMBL2553195 0.80 ALDH1A1 (0.39) SMN1; SMN2CYP1A2
SCHEMBL5332171 0.80 ALDH1A1 (0.39) SMN1; SMN2CYP1A2
SCHEMBL4327063 0.80 ALDH1A1 (0.39) SMN1; SMN2CYP1A2
SCHEMBL754867 0.80 ALDH1A1 (0.39) SMN1; SMN2CYP1A2
SCHEMBL17140651 0.75 SMN1; SMN2 (0.44) SMN1; SMN2CYP1A2GAACTSKCA12
SCHEMBL17140740 0.75 SMN1; SMN2 (0.34) SMN1; SMN2CYP1A2GAACTSKCA12
SCHEMBL17140956 0.73 GAA (0.49) SMN1; SMN2CYP1A2GAACTSKCTSS
SCHEMBL755767 0.73 SMN1; SMN2 (0.34) SMN1; SMN2CYP1A2GAACA12CA1
SCHEMBL17140577 0.73 MAPT (0.40) SMN1; SMN2GAAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2073635-A1 MACROCYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2009-07-01 EP disclosed
WO-2008045250-A1 MACROCYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-04-17 WO disclosed